课题基金 / 基金详情

Peptide Morphing: Rational Design of Separase Inhibitors

Peptide Morphing: Rational Design of Separase Inhibitors
肽变形:分离酶抑制剂的合理设计
批准号:
6585224
负责人:
Webster L Santos
金额:
$3.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2006-04-30

项目摘要

项目成果

Webster L Santos的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Separase has recently been identified as a cysteine protease that cleaves the Scc1 subunit of cohesin, a complex protein that physically connects sister chromatids and serves important functions in mitotic spindle dynamics. This proposal applies the recently described technique of peptide morphing in the rational design and synthesis of small nonpeptidic molecules to bind and inhibit separase. It is our hope that this proposal will demonstrate the power of peptide morphing by presenting a functionally rich and stereo diversified ligand structure to a protein target of urgent biologic interest and significance. Inhibition of separase, particularly at the active site, should shed light on key aspects of chromosome biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SPNS2 inhibitors as renal fibrosis therapy
  • 批准号:
    10759681
  • 项目类别:
  • 资助金额:
    $30.14万
  • 财政年份:
    2023
  • 负责人:
    Webster L Santos
  • 依托单位:
Therapeutic Mitochondrial Uncouplers
Therapeutic Mitochondrial Uncouplers
Therapeutic Mitochondrial Uncouplers
海外基金